TY - JOUR
AU1 - McGauley, G.A.
AU2 - Cuneo, R.C.
AU3 - Salomon, F.
AU4 - Sönksen, P.H.
AB - The effect of recombinant-DNA human growth hormone treatment on psychological well-being and quality of life was studied in adults with GH deficiency (GHD). 24 adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial. Quality of life assessments were performed at entry, 1 and 6 months by means of self-rating questionnaires. This study reports significantly lower scores on quality of life assessment in the GH-deficient patients at entry compared with matched controls, indicating that this population may be psychologically compromised. Preliminary analysis of treatment results shows that after 6 months, those patients receiving active treatment experienced less perceived illness than the placebo group. Significant psychological improvements were noted in the patients’ perception of their energy level and mood.
TI - Psychological Well-Being before and after Growth Hormone Treatment in Adults with Growth Hormone Deficiency
JF - Hormone Research in Paediatrics
DO - 10.1159/000181584
DA - 1990-01-01
UR - https://www.deepdyve.com/lp/karger/psychological-well-being-before-and-after-growth-hormone-treatment-in-iylSODPZI8
SP - 52
EP - 54
VL - 33
IS - Suppl 4
DP - DeepDyve
ER -